Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma.
Ward JP, Berrien-Elliott MM, Gomez F, Luo J, Becker-Hapak M, Cashen AF, Wagner-Johnston ND, Maddocks K, Mosior M, Foster M, Krysiak K, Schmidt A, Skidmore ZL, Desai S, Watkins MP, Fischer A, Griffith M, Griffith OL, Fehniger TA, Bartlett NL. Ward JP, et al. Among authors: fischer a. Blood. 2022 Mar 31;139(13):1999-2010. doi: 10.1182/blood.2021011894. Blood. 2022. PMID: 34780623 Free PMC article. Clinical Trial.
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas.
Foley N, Riedell PA, Bartlett NL, Cashen AF, Kahl BS, Fehniger TA, Fischer A, Moreno C, Liu J, Carson KR, Mehta-Shah N. Foley N, et al. Among authors: fischer a. Clin Lymphoma Myeloma Leuk. 2024 Dec 4:S2152-2650(24)02436-4. doi: 10.1016/j.clml.2024.11.015. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39725584
Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplant.
Guazzo R, Fischer A, Vannucchi M, Fabbri A, Garosi G, Granai M, Tripodi SA, Oehl-Huber K, Bens S, Moawia A, Cencini E, Lazzi S, Siebert R, Leoncini L. Guazzo R, et al. Among authors: fischer a. Pathol Res Pract. 2024 Dec 17;266:155777. doi: 10.1016/j.prp.2024.155777. Online ahead of print. Pathol Res Pract. 2024. PMID: 39708522 Free article.
Navigating Illumina DNA methylation data: biology versus technical artefacts.
Glaser S, Kretzmer H, Kolassa IT, Schlesner M, Fischer A, Fenske I, Siebert R, Ammerpohl O. Glaser S, et al. Among authors: fischer a. NAR Genom Bioinform. 2024 Dec 18;6(4):lqae181. doi: 10.1093/nargab/lqae181. eCollection 2024 Dec. NAR Genom Bioinform. 2024. PMID: 39703427 Free PMC article.
Vaccine policies in France and Europe.
Fischer A, Peretti-Watel P, Ward J. Fischer A, et al. Curr Opin Immunol. 2024 Dec 14;92:102513. doi: 10.1016/j.coi.2024.102513. Online ahead of print. Curr Opin Immunol. 2024. PMID: 39675153 Free article. Review.
Neuroinflammation in Alzheimer disease.
Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, Brosseron F, Teunissen C, Zetterberg H, Jacobs AH, Edison P, Ramirez A, Cruchaga C, Lambert JC, Laza AR, Sanchez-Mut JV, Fischer A, Castro-Gomez S, Stein TD, Kleineidam L, Wagner M, Neher JJ, Cunningham C, Singhrao SK, Prinz M, Glass CK, Schlachetzki JCM, Butovsky O, Kleemann K, De Jaeger PL, Scheiblich H, Brown GC, Landreth G, Moutinho M, Grutzendler J, Gomez-Nicola D, McManus RM, Andreasson K, Ising C, Karabag D, Baker DJ, Liddelow SA, Verkhratsky A, Tansey M, Monsonego A, Aigner L, Dorothée G, Nave KA, Simons M, Constantin G, Rosenzweig N, Pascual A, Petzold GC, Kipnis J, Venegas C, Colonna M, Walter J, Tenner AJ, O'Banion MK, Steinert JR, Feinstein DL, Sastre M, Bhaskar K, Hong S, Schafer DP, Golde T, Ransohoff RM, Morgan D, Breitner J, Mancuso R, Riechers SP. Heneka MT, et al. Among authors: fischer a. Nat Rev Immunol. 2024 Dec 9. doi: 10.1038/s41577-024-01104-7. Online ahead of print. Nat Rev Immunol. 2024. PMID: 39653749 Review.
5,271 results